Global Hereditary Cancer Testing Market Research Report 2022

SKU ID : QYR-21348578 | Publishing Date : 18-Jul-2022 | No. of pages : 104

Request a free Sample

Detailed TOC of Global Hereditary Cancer Testing Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 RNA Testing
        1.2.3 DNA Testing
    1.3 Market by Application
        1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Breast Cancer
        1.3.3 Gastrointestinal Cancer
        1.3.4 Prostate Cancer
        1.3.5 Respiratory/Lung Cancer
        1.3.6 Other Cancers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hereditary Cancer Testing Market Perspective (2017-2028)
    2.2 Hereditary Cancer Testing Growth Trends by Region
        2.2.1 Hereditary Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2017-2022)
        2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028)
    2.3 Hereditary Cancer Testing Market Dynamics
        2.3.1 Hereditary Cancer Testing Industry Trends
        2.3.2 Hereditary Cancer Testing Market Drivers
        2.3.3 Hereditary Cancer Testing Market Challenges
        2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hereditary Cancer Testing Players by Revenue
        3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2017-2022)
        3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
    3.4 Global Hereditary Cancer Testing Market Concentration Ratio
        3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2021
    3.5 Hereditary Cancer Testing Key Players Head office and Area Served
    3.6 Key Players Hereditary Cancer Testing Product Solution and Service
    3.7 Date of Enter into Hereditary Cancer Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
    4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2017-2022)
    4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028)
5 Hereditary Cancer Testing Breakdown Data by Application
    5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2017-2022)
    5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hereditary Cancer Testing Market Size (2017-2028)
    6.2 North America Hereditary Cancer Testing Market Size by Country (2017-2022)
    6.3 North America Hereditary Cancer Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hereditary Cancer Testing Market Size (2017-2028)
    7.2 Europe Hereditary Cancer Testing Market Size by Country (2017-2022)
    7.3 Europe Hereditary Cancer Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2017-2028)
    8.2 Asia-Pacific Hereditary Cancer Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hereditary Cancer Testing Market Size (2017-2028)
    9.2 Latin America Hereditary Cancer Testing Market Size by Country (2017-2022)
    9.3 Latin America Hereditary Cancer Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2017-2028)
    10.2 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Ambry Genetics (Konica Minota)
        11.1.1 Ambry Genetics (Konica Minota) Company Detail
        11.1.2 Ambry Genetics (Konica Minota) Business Overview
        11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
        11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.1.5 Ambry Genetics (Konica Minota) Recent Development
    11.2 Asper Biogene
        11.2.1 Asper Biogene Company Detail
        11.2.2 Asper Biogene Business Overview
        11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
        11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.2.5 Asper Biogene Recent Development
    11.3 Natera
        11.3.1 Natera Company Detail
        11.3.2 Natera Business Overview
        11.3.3 Natera Hereditary Cancer Testing Introduction
        11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.3.5 Natera Recent Development
    11.4 Caris Life Sciences
        11.4.1 Caris Life Sciences Company Detail
        11.4.2 Caris Life Sciences Business Overview
        11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
        11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.4.5 Caris Life Sciences Recent Development
    11.5 BioReference Laboratories (GeneDx)
        11.5.1 BioReference Laboratories (GeneDx) Company Detail
        11.5.2 BioReference Laboratories (GeneDx) Business Overview
        11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
        11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.5.5 BioReference Laboratories (GeneDx) Recent Development
    11.6 LabSolutions
        11.6.1 LabSolutions Company Detail
        11.6.2 LabSolutions Business Overview
        11.6.3 LabSolutions Hereditary Cancer Testing Introduction
        11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.6.5 LabSolutions Recent Development
    11.7 Progenity，Inc
        11.7.1 Progenity，Inc Company Detail
        11.7.2 Progenity，Inc Business Overview
        11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
        11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.7.5 Progenity，Inc Recent Development
    11.8 ARUP Laboratories
        11.8.1 ARUP Laboratories Company Detail
        11.8.2 ARUP Laboratories Business Overview
        11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
        11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.8.5 ARUP Laboratories Recent Development
    11.9 Myriad
        11.9.1 Myriad Company Detail
        11.9.2 Myriad Business Overview
        11.9.3 Myriad Hereditary Cancer Testing Introduction
        11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.9.5 Myriad Recent Development
    11.10 NeoGenomics
        11.10.1 NeoGenomics Company Detail
        11.10.2 NeoGenomics Business Overview
        11.10.3 NeoGenomics Hereditary Cancer Testing Introduction
        11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.10.5 NeoGenomics Recent Development
    11.11 Blueprint Genetics
        11.11.1 Blueprint Genetics Company Detail
        11.11.2 Blueprint Genetics Business Overview
        11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction
        11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.11.5 Blueprint Genetics Recent Development
    11.12 CellMax Life
        11.12.1 CellMax Life Company Detail
        11.12.2 CellMax Life Business Overview
        11.12.3 CellMax Life Hereditary Cancer Testing Introduction
        11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.12.5 CellMax Life Recent Development
    11.13 Fulgent Genetics
        11.13.1 Fulgent Genetics Company Detail
        11.13.2 Fulgent Genetics Business Overview
        11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction
        11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.13.5 Fulgent Genetics Recent Development
    11.14 Strand Life Sciences
        11.14.1 Strand Life Sciences Company Detail
        11.14.2 Strand Life Sciences Business Overview
        11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction
        11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.14.5 Strand Life Sciences Recent Development
    11.15 Myogenes
        11.15.1 Myogenes Company Detail
        11.15.2 Myogenes Business Overview
        11.15.3 Myogenes Hereditary Cancer Testing Introduction
        11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.15.5 Myogenes Recent Development
    11.16 LabCorp
        11.16.1 LabCorp Company Detail
        11.16.2 LabCorp Business Overview
        11.16.3 LabCorp Hereditary Cancer Testing Introduction
        11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.16.5 LabCorp Recent Development
    11.17 Quest Diagnostics
        11.17.1 Quest Diagnostics Company Detail
        11.17.2 Quest Diagnostics Business Overview
        11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction
        11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.17.5 Quest Diagnostics Recent Development
    11.18 Pathway Genomics
        11.18.1 Pathway Genomics Company Detail
        11.18.2 Pathway Genomics Business Overview
        11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction
        11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.18.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Hereditary Cancer Testing Market Research Report 2022

List of Tables
    Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of RNA Testing
    Table 3. Key Players of DNA Testing
    Table 4. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hereditary Cancer Testing Market Share by Region (2017-2022)
    Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hereditary Cancer Testing Market Share by Region (2023-2028)
    Table 10. Hereditary Cancer Testing Market Trends
    Table 11. Hereditary Cancer Testing Market Drivers
    Table 12. Hereditary Cancer Testing Market Challenges
    Table 13. Hereditary Cancer Testing Market Restraints
    Table 14. Global Hereditary Cancer Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hereditary Cancer Testing Market Share by Players (2017-2022)
    Table 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021)
    Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hereditary Cancer Testing Product Solution and Service
    Table 21. Date of Enter into Hereditary Cancer Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hereditary Cancer Testing Revenue Market Share by Application (2017-2022)
    Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hereditary Cancer Testing Revenue Market Share by Application (2023-2028)
    Table 31. North America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Ambry Genetics (Konica Minota) Company Detail
    Table 42. Ambry Genetics (Konica Minota) Business Overview
    Table 43. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
    Table 44. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 45. Ambry Genetics (Konica Minota) Recent Development
    Table 46. Asper Biogene Company Detail
    Table 47. Asper Biogene Business Overview
    Table 48. Asper Biogene Hereditary Cancer Testing Product
    Table 49. Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 50. Asper Biogene Recent Development
    Table 51. Natera Company Detail
    Table 52. Natera Business Overview
    Table 53. Natera Hereditary Cancer Testing Product
    Table 54. Natera Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 55. Natera Recent Development
    Table 56. Caris Life Sciences Company Detail
    Table 57. Caris Life Sciences Business Overview
    Table 58. Caris Life Sciences Hereditary Cancer Testing Product
    Table 59. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 60. Caris Life Sciences Recent Development
    Table 61. BioReference Laboratories (GeneDx) Company Detail
    Table 62. BioReference Laboratories (GeneDx) Business Overview
    Table 63. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
    Table 64. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 65. BioReference Laboratories (GeneDx) Recent Development
    Table 66. LabSolutions Company Detail
    Table 67. LabSolutions Business Overview
    Table 68. LabSolutions Hereditary Cancer Testing Product
    Table 69. LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 70. LabSolutions Recent Development
    Table 71. Progenity，Inc Company Detail
    Table 72. Progenity，Inc Business Overview
    Table 73. Progenity，Inc Hereditary Cancer Testing Product
    Table 74. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 75. Progenity，Inc Recent Development
    Table 76. ARUP Laboratories Company Detail
    Table 77. ARUP Laboratories Business Overview
    Table 78. ARUP Laboratories Hereditary Cancer Testing Product
    Table 79. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 80. ARUP Laboratories Recent Development
    Table 81. Myriad Company Detail
    Table 82. Myriad Business Overview
    Table 83. Myriad Hereditary Cancer Testing Product
    Table 84. Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 85. Myriad Recent Development
    Table 86. NeoGenomics Company Detail
    Table 87. NeoGenomics Business Overview
    Table 88. NeoGenomics Hereditary Cancer Testing Product
    Table 89. NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 90. NeoGenomics Recent Development
    Table 91. Blueprint Genetics Company Detail
    Table 92. Blueprint Genetics Business Overview
    Table 93. Blueprint Genetics Hereditary Cancer TestingProduct
    Table 94. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 95. Blueprint Genetics Recent Development
    Table 96. CellMax Life Company Detail
    Table 97. CellMax Life Business Overview
    Table 98. CellMax Life Hereditary Cancer TestingProduct
    Table 99. CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 100. CellMax Life Recent Development
    Table 101. Fulgent Genetics Company Detail
    Table 102. Fulgent Genetics Business Overview
    Table 103. Fulgent Genetics Hereditary Cancer TestingProduct
    Table 104. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 105. Fulgent Genetics Recent Development
    Table 106. Strand Life Sciences Company Detail
    Table 107. Strand Life Sciences Business Overview
    Table 108. Strand Life Sciences Hereditary Cancer TestingProduct
    Table 109. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 110. Strand Life Sciences Recent Development
    Table 111. Myogenes Company Detail
    Table 112. Myogenes Business Overview
    Table 113. Myogenes Hereditary Cancer TestingProduct
    Table 114. Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 115. Myogenes Recent Development
    Table 116. LabCorp Company Detail
    Table 117. LabCorp Business Overview
    Table 118. LabCorp Hereditary Cancer TestingProduct
    Table 119. LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 120. LabCorp Recent Development
    Table 121. Quest Diagnostics Company Detail
    Table 122. Quest Diagnostics Business Overview
    Table 123. Quest Diagnostics Hereditary Cancer TestingProduct
    Table 124. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 125. Quest Diagnostics Recent Development
    Table 126. Pathway Genomics Company Detail
    Table 127. Pathway Genomics Business Overview
    Table 128. Pathway Genomics Hereditary Cancer TestingProduct
    Table 129. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 130. Pathway Genomics Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2021 VS 2028
    Figure 2. RNA Testing Features
    Figure 3. DNA Testing Features
    Figure 4. Global Hereditary Cancer Testing Market Share by Application in 2021 & 2028
    Figure 5. Breast Cancer Case Studies
    Figure 6. Gastrointestinal Cancer Case Studies
    Figure 7. Prostate Cancer Case Studies
    Figure 8. Respiratory/Lung Cancer Case Studies
    Figure 9. Other Cancers Case Studies
    Figure 10. Hereditary Cancer Testing Report Years Considered
    Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Hereditary Cancer Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hereditary Cancer Testing Market Share by Region: 2021 VS 2028
    Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2021
    Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2021
    Figure 17. North America Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Hereditary Cancer Testing Market Share by Country (2017-2028)
    Figure 19. United States Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Hereditary Cancer Testing Market Share by Country (2017-2028)
    Figure 23. Germany Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Hereditary Cancer Testing Market Share by Region (2017-2028)
    Figure 31. China Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Hereditary Cancer Testing Market Share by Country (2017-2028)
    Figure 39. Mexico Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Hereditary Cancer Testing Market Share by Country (2017-2028)
    Figure 43. Turkey Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 46. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 47. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 48. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 49. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 50. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 51. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 52. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 53. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 54. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 55. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 56. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 57. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 58. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 59. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 60. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 61. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 62. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Keyplayers in Global Hereditary Cancer Testing Market Research Report 2022

Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics